Trials / Completed
CompletedNCT05100368
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patients | Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis |
Timeline
- Start date
- 2021-04-02
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2021-10-29
- Last updated
- 2023-07-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05100368. Inclusion in this directory is not an endorsement.